Study to Assess the Efficacy of Brachytherapy With or Without Hormone Therapy, Using Triptorelin 22.5mg in Patients With Recurrence of Prostate Cancer
Condition: Prostate CancerInterventions: Other: Brachytherapy + Decapeptyl® SR 22.5mg Triptorelin; Radiation: BrachytherapySponsor: IpsenTerminated - verified April 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Brachytherapy | Cancer | Cancer & Oncology | Hormonal Therapy | Hormones | Prostate Cancer | Research | Study